BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Plamotamab readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Plamotamab\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07230353-6393@assetmemo.bio
DTSTAMP:20261121T005900Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Plamotamab: Phase 1 readout est. (NCT07230353)
DESCRIPTION:Plamotamab\, phase 1\, Rheumatoid Arthritis.\nStudy: A Phase 1b
  Open-label Study to Evaluate Safety of Plamotamab in Participants With Rh
 eumatoid Arthritis\nEstimated primary completion: June 2028. This is a Cli
 nicalTrials.gov estimate\, not a confirmed readout date\, and it can move.
 \nDrug page: https://assetmemo.bio/drug/plamotamab#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT07230353
URL:https://assetmemo.bio/drug/plamotamab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
